Abstract
Pituitary hyperplasia secondary to primary hypothyroidism has been reported in the literature in both adults and children. We report a case of a young woman who was diagnosed with hypothyroidism in her teenage years. Despite frequent follow-up, her TSH levels remained greater than 100 mIU/ml. A few years later, pituitary enlargement was found on an MRI at a time when her TSH was 177 mIU/ml and her free T4 was 0.2 ng/dl. Observed administration of 600 mcg of L-thyroxine was performed to determine the effectiveness of hormone absorption. Total T4 levels of 0.2 rose to 7.1 mcg/dl at two hours with a decrease in her TSH levels from 88.6 to 66.8 mIU/ml at 24 hours. With the exception of one short period, her TSH levels have remained elevated over eight years of observation without change in the size of the pituitary mass.
In our review of the literature, primary uncontrolled hypothyroidism has been described as a precursor to pituitary hyperplasia. In these patients, TSH-secreting adenomas were distinguished from pituitary hyperplasia by a blunted TRH stimulation test, elevated alpha subunit concentration values, and elevated alpha subunit concentration/TSH ratios. TSH levels ranged from 98 to 732 mIU/ml in adults, and even higher values in children. Following adequate hormone replacement with L-thyroxine doses of 25 to 300 mcg/day, both symptoms and pituitary hyperplasia regressed on average within a few months.
Similar content being viewed by others
References
Sarlis N, Brucker-Davis F, Doppman J, Skarulis M. MRI-demonstrable regression of a pituitary mass in a case of primary hypothyroidism after a week of acute thyroid hormone therapy. J Clin Endocrinol Metabol 1997;82:808–811.
Valenta L, Tamkin J, Sostrin R, Elias A, Eisenberg H. Regression of a pituitary adenoma following levothyroxine therapy of primary hypothyroidism. Fertility and Sterility 1983;40:389–392.
Fujii T, Misumi S, Onoda K, Fukuda H, Ibuki Y. Pituitary enlargement with target organ deficiency: Hypothyroidism and hypogonadims. Surg Neurol 1987;28:390–394.
Yamamoto, Saito K, Takai T, Naito M, Yoshida. Visual field defects and pituitary enlargement in primary hypothyroidism. J Clin Endocrinol Metabol 1983;57:283–287.
Brucker-Davis F, Oldfield E, Skarulis M, Doppman J, Weintraub B. Thyrotropin-secreting pituitary tumors: Diagnostic criteria, thyroid hormone sensitivity and treatment outcome in 25 patients followed at the National Institute of Health. J Clin Endocrinol Metabol 84:476–486.
Gesundheit N, Petrick P, Nissim M, Dahlberg P, Doppman J, Emerson C, Braverman L, Oldfield E, Weintraub B. Thyrotropin-secreting pituitary adenomas: Clinical and biochemical heterogeneity. Ann Int Med 1989;111:827–835.
Desai M, Mehta R, Choksi C, Colaco M, Prisca M. Pituitary enlargement on magnetic resonance imaging in congenital hypothyroidism. Arch Pediatr Adol Med 1996;150:623–628.
Pita J, Shafey S, Pina R. Diminution of large pituitary tumor after replacement therapy for primary hypothyroidism. Neurology 1979;29:1169–1172.
Hutchins WW, Crues JV, Miya P, Pojunas KW. MR demonstration of pituitary hyperplasia and regression. Amer J Neuroradiol 1990;11:410.
Young M, Kattner K, Gupta K. Pituitary hyperplasia resulting from primary hypothyroidism mimicking macroadenomas. British J Neurosurgery 1999;13:138–142.
Atchison J, Lee P, Allbright L. Reversible suprasellar pituitary mass secondary to hypothyroidism. JAMA 1989;262:3175–3177.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Joshi, A.S., Woolf, P.D. Pituitary Hyperplasia Secondary to Primary Hypothyroidism: A Case Report and Review of the Literature. Pituitary 8, 99–103 (2005). https://doi.org/10.1007/s11102-005-3281-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11102-005-3281-8